Analyze Diet
Equine veterinary journal2020; 52(6); 841-847; doi: 10.1111/evj.13254

First report of equine parvovirus-hepatitis-associated Theiler’s disease in Europe.

Abstract: Equine parvovirus-hepatitis (EqPV-H) has been proposed as the aetiological cause of Theiler's disease, also known as serum hepatitis. EqPV-H-associated Theiler's disease has not been previously reported in Europe. Objective: To determine whether EqPV-H infection was associated with a 2018-2019 outbreak of Theiler's disease in four horses on a studfarm. Methods: Descriptive case series. Methods: The medical records of four horses from the same farm diagnosed with fatal Theiler's disease were examined retrospectively. Information collected included a clinical history, physical examination findings, tetanus antitoxin exposure, serum biochemistry and necropsy reports. Liver tissue from all four horses was tested for EqPV-H using PCR and in situ hybridisation (ISH) assays. Results: Three of the horses had a history of recent (7-11 weeks) tetanus antitoxin administration. Liver tissue from all four horses tested positive for EqPV-H with PCR. In situ hybridisation revealed a widespread distribution of viral nucleic acid in hepatocytes in one case, and a more sporadic distribution in the remaining three cases. Conclusions: Case controls were not available from the farm in question given the retrospective nature of analysis. Conclusions: This case series documents the first reported EqPV-H-associated Theiler's disease in Europe and the first use of ISH to visualise the viral nucleic acid in liver tissues of horses with Theiler's disease.
Publication Date: 2020-03-25 PubMed ID: 32145096PubMed Central: PMC7483838DOI: 10.1111/evj.13254Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates a 2018-2019 outbreak of Theiler’s disease, suspected to be associated with Equine parvovirus-hepatitis (EqPV-H), in four horses from a single farm in Europe. This is the first recorded instance of EqPV-H linked Theiler’s disease in Europe.

Background

  • Theiler’s disease, also known as serum hepatitis, is a severe liver disease in horses which can often result in fatal outcomes. It has been suspected that EqPV-H is a cause of this condition.
  • This particular form of Theiler’s disease associated with EqPV-H was not known to exist in Europe prior to this research.
  • The purpose of this study was to understand the link between EqPV-H infection and an outbreak of Theiler’s disease on a European horse farm during 2018-2019.

Methodology

  • The researchers conducted a retrospective review of the medical records of four horses from the same farm that were diagnosed with fatal Theiler’s disease.
  • Data collected from the records included information about the horses’ clinical history, physical examination results, exposure to tetanus antitoxin, serum biochemistry, and necropsy reports.
  • The researchers tested liver tissue samples from all four affected horses for EqPV-H using a method called polymerase chain reaction (PCR) and in situ hybridisation (ISH).

Results

  • PCR tests confirmed the presence of EqPV-H in the liver tissue of all four horses suffering from Theiler’s disease.
  • Three of the four horses had received a tetanus antitoxin 7-11 weeks prior to being diagnosed with Theiler’s disease.
  • In situ hybridisation allowed the researchers to locate and visualise the distribution of viral nucleic acid in the hepatocytes of the horses’ livers. One horse showed a widespread distribution of the virus, while the remaining three horses exhibited a more sporadic distribution.

Conclusions

  • The study did not have controls from the same farm due to the retrospective nature of the research. Therefore, it couldn’t conclusively establish EqPV-H as the definite cause of the outbreak.
  • Despite this, the research marks the first reported instance of EqPV-H-associated Theiler’s disease in Europe, and demonstrates the use of ISH as a valuable tool in the identification and visualisation of viral nucleic acids in horses diagnosed with Theiler’s disease.

Cite This Article

APA
Vengust M, Jager MC, Zalig V, Cociancich V, Laverack M, Renshaw RW, Dubovi E, Tomlinson JE, Van de Walle GR, Divers TJ. (2020). First report of equine parvovirus-hepatitis-associated Theiler’s disease in Europe. Equine Vet J, 52(6), 841-847. https://doi.org/10.1111/evj.13254

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 52
Issue: 6
Pages: 841-847

Researcher Affiliations

Vengust, Modest
  • University of Ljubljana, Veterinary Faculty, Ljubljana, Slovenia.
Jager, Mason C
  • Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Zalig, Valentina
  • University of Ljubljana, Veterinary Faculty, Ljubljana, Slovenia.
  • Marc Veterinary Services, Sezana, Slovenia.
Cociancich, Vasilij
  • University of Ljubljana, Veterinary Faculty, Ljubljana, Slovenia.
Laverack, Melissa
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Renshaw, Randall W
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Dubovi, Edward
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Tomlinson, Joy E
  • Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Van de Walle, Gerlinde R
  • Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Divers, Thomas J
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.

MeSH Terms

  • Animals
  • Europe / epidemiology
  • Hepatitis
  • Horse Diseases / epidemiology
  • Horse Diseases / etiology
  • Horses
  • Parvoviridae Infections / veterinary
  • Parvovirus
  • Retrospective Studies

Grant Funding

  • K08AI141767 / National Institute of Allergy and Infectious Diseases
  • P4-0053 / Slovenian Research Agency Fund
  • K08 AI141767 / NIAID NIH HHS
  • Harry M. Zweig Memorial Fund for Equine Research
  • 2016-67015-24765 / National Institute of Food and Agriculture
  • The Niarchos Family

Conflict of Interest Statement

Authors’ declaration of interests. No competing interests have been declared.

References

This article includes 27 references
  1. Theiler A. Acute liver-atrophy and parenchymatous hepatitis in horses. Union of South Africa. Dept. of Agriculture. 5th and 6th Repts. of the Director of Veterinary Research.
  2. Hjerpe CA. Serum Hepatitis in the Horse. J. Am. Vet. Med. Assoc 144, 734–740.
    pubmed: 14156990
  3. Rose J, Immenschuh R, Rose E. Serum hepatitis in the horse. Proceedings of the annual convention of the American Association of Equine Practitioners 175–185.
  4. Thomsett LR. Acute Hepatic Failure in the Horse. Equine Veterinary Journal 3, 15–19.
    pubmed: 5161355
  5. Step DL, Blue JT, Dill SG. Penicillin-induced hemolytic anemia and acute hepatic failure following treatment of tetanus in a horse. Cornell Vet 81, 13–18.
    pubmed: 1993388
  6. Messer NT, Johnson PJ. Serum hepatitis in two brood mares. J. Am. Vet. Med. Assoc 204, 1790–1792.
    pubmed: 8063602
  7. Guglick MA, MacAllister CG, Ely RW, Edwards WC. Hepatic disease associated with administration of tetanus antitoxin in eight horses. J. Am. Vet. Med. Assoc 206, 1737–1740.
    pubmed: 7782247
  8. Messer NT, Johnson PJ. Idiopathic acute hepatic disease in horses: 12 cases (1982–1992). J. Am. Vet. Med. Assoc 204, 1934–1937.
    pubmed: 8077140
  9. Chandriani S, Skewes-Cox P, Zhong W, Ganem DE, Divers TJ, Van Blaricum AJ, Tennant BC, Kistler AL. Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis. Proc. Natl. Acad. Sci. U.S.A 110, E1407–1415.
    pmc: PMC3625295pubmed: 23509292
  10. Aleman M, Nieto JE, Carr EA, Carlson GP. Serum Hepatitis Associated with Commercial Plasma Transfusion in Horses. Journal of Veterinary Internal Medicine 19: 120–122.
    pubmed: 15715060
  11. Panciera RJ. Serum hepatitis in the horse. J. Am. Vet. Med. Assoc 155, 408–410.
    pubmed: 5816124
  12. Tomlinson JE, Tennant BC, Struzyna A, Mrad D, Browne N, Whelchel D, Johnson PJ, Jamieson C, Löhr CV, Bildfell R, McKenzie EC, Laverack M, Renshaw RW, Dubovi E, Kapoor A, Meirs RS, Belgrave R, Engiles J, Van de Walle GR, Divers TJ. Viral testing of 10 cases of Theiler’s disease and 37 in-contact horses in the absence of equine biologic product administration: A prospective study (2014–2018). Journal of Veterinary Internal Medicine 33, 258–265.
    pmc: PMC6335540pubmed: 30520132
  13. Tomlinson JE, Kapoor A, Kumar A, Tennant BC, Laverack MA, Beard L, Delph K, Davis E, Schott II H, Lascola K, Holbrook TC, Johnson P, Taylor SD, McKenzie E, Carter-Arnold J, Setlakwe E, Fultz L, Brakenhoff J, Ruby R, Trivedi S, Van de Walle GR, Renshaw RW, Dubovi EJ, Divers TJ. Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014–2018). Journal of Veterinary Internal Medicine 33, 251–257.
    pmc: PMC6335536pubmed: 30520162
  14. Divers TJ, Tennant BC, Kumar A, McDonough S, Cullen J, Bhuva N, Jain K, Chauhan LS, Scheel TKH, Lipkin WI, Laverack M, Trivedi S, Srinivasa S, Beard L, Rice CM, Burbelo PD, Renshaw RW, Dubovi E, Kapoor A. New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product. Emerging Infectious Diseases 24, 303–310.
    pmc: PMC5782890pubmed: 29350162
  15. Meister TL, Tegtmeyer B, Postel A, Cavalleri J-MV, Todt D, Stang A, Steinmann E. Equine Parvovirus-Hepatitis Frequently Detectable in Commercial Equine Serum Pools. Viruses 11.
    pmc: PMC6563276pubmed: 31117220
  16. Lu G, Sun L, Ou J, Xu H, Wu L, Li S. Identification and genetic characterization of a novel parvovirus associated with serum hepatitis in horses in China. Emerg Microbes Infect 7, 170.
    pmc: PMC6198012pubmed: 30348940
  17. Wang F, Flanagan J, Su N, Wang L-C, Bui S, Nielson A, Wu X, Vo H-T, Ma X-J, Luo Y. RNAscope. J Mol Diagn 14, 22–29.
    pmc: PMC3338343pubmed: 22166544
  18. Ramsay JD, Evanoff R, Jr TEW, Divers TJ, Knowles DP, Mealey RH. Experimental Transmission of Equine Hepacivirus in Horses as a Model for Hepatitis C Virus. 61, 14.
    pubmed: 25580897
  19. Pfaender S, Cavalleri JMV, Walter S, Doerrbecker J, Campana B, Brown RJP, Burbelo PD, Postel A, Hahn K, Anggakusuma, Riebesehl N, Baumgärtner W, Becher P, Heim MH, Pietschmann T, Feige K, Steinmann E. Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses. Hepatology 61, 447–459.
    pubmed: 25212983
  20. Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero-Brey I, Gather T, Brown RJP, Hahn K, Puff C, Pfankuche VM, Hansmann F, Postel A, Becher P, Thiel V, Kalinke U, Wagner B, Bartenschlager R, Baumgärtner W, Feige K, Pietschmann T, Cavalleri JMV, Steinmann E. Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci U S A 114, E2430–E2439.
    pmc: PMC5373355pubmed: 28275093
  21. Scheel TKH, Kapoor A, Nishiuchi E, Brock KV, Yu Y, Andrus L, Gu M, Renshaw RW, Dubovi EJ, McDonough SP, Van de Walle GR, Lipkin WI, Divers TJ, Tennant BC, Rice CM. Characterization of nonprimate hepacivirus and construction of a functional molecular clone. Proc. Natl. Acad. Sci. U.S.A 112, 2192–2197.
    pmc: PMC4343093pubmed: 25646476
  22. Kapoor A, Simmonds P, Cullen JM, Scheel TKH, Medina JL, Giannitti F, Nishiuchi E, Brock KV, Burbelo PD, Rice CM, Lipkin WI. Identification of a Pegivirus (GB Virus-Like Virus) That Infects Horses. J Virol 87, 7185–7190.
    pmc: PMC3676142pubmed: 23596285
  23. Hedegaard J, Thorsen K, Lund MK, Hein A-MK, Hamilton-Dutoit SJ, Vang S, Nordentoft I, Birkenkamp-Demtröder K, Kruhøffer M, Hager H, Knudsen B, Andersen CL, Sørensen KD, Pedersen JS, Ørntoft TF, Dyrskjøt L. Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue. PLoS ONE 9, e98187.
    pmc: PMC4039489pubmed: 24878701
  24. Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD, Duncavage EJ. Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens. The Journal of Molecular Diagnostics 15, 623–633.
    pmc: PMC4912568pubmed: 23810758
  25. Anonymous. ProteqFlu-Te. European Medicines Agency .
  26. Pfankuche V, Hahn K, Bodewes R, Hansmann F, Habierski A, Haverkamp A-K, Pfaender S, Walter S, Baechlein C, Postel A, Steinmann E, Becher P, Osterhaus A, Baumgärtner W, Puff C. Comparison of Different In Situ Hybridization Techniques for the Detection of Various RNA and DNA Viruses. Viruses 10, 384.
    pmc: PMC6071121pubmed: 30037026
  27. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clin Microbiol Rev 9, 18–33.
    pmc: PMC172879pubmed: 8665474